|
1
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Davidson SM, Ferdinandy P, Andreadou I,
Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM,
Hausenloy DJ, et al: Multitarget strategies to reduce myocardial
ischemia/reperfusion injury: JACC review topic of the week. J Am
Coll Cardiol. 73:89–99. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gottlieb RA and Pourpirali S: Lost in
translation: miRNAs and mRNAs in ischemic preconditioning and
ischemia/reperfusion injury. J Mol Cell Cardiol. 95:70–77.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Siebert V, Allencherril J, Ye Y, Wehrens
XHT and Birnbaum Y: The role of non-coding RNAs in ischemic
myocardial reperfusion injury. Cardiovasc Drugs Ther. 33:489–498.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang X, Zhang X, Ren XP, Chen J, Liu H,
Yang J, Medvedovic M, Hu Z and Fan GC: MicroRNA-494 targeting both
proapoptotic and antiapoptotic proteins protects against
ischemia/reperfusion-induced cardiac injury. Circulation.
122:1308–1318. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lovren F, Pan Y, Quan A, Singh KK, Shukla
PC, Gupta N, Steer BM, Ingram AJ, Gupta M, Al-Omran M, et al:
MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation.
126 (Suppl 1):S81–S90. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Caruso P, Dempsie Y, Stevens HC, McDonald
RA, Long L, Lu R, White K, Mair KM, McClure JD, Southwood M, et al:
A role for miR-145 in pulmonary arterial hypertension: Evidence
from mouse models and patient samples. Circ Res. 111:290–300.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu Z, Tao B, Fan S, Pu Y, Xia H and Xu L:
MicroRNA-145 protects against myocardial ischemia reperfusion
injury via CaMKII-mediated antiapoptotic and anti-inflammatory
pathways. Oxid Med Cell Longev. 2019(8948657)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Qi Z, Li S, Su Y, Zhang J, Kang Y, Huang
Y, Jin F and Xing Q: Role of microRNA-145 in protection against
myocardial ischemia/reperfusion injury in mice by regulating
expression of GZMK with the treatment of sevoflurane. J Cell
Physiol: Mar 14, 2019 (Epub ahead of print).
|
|
12
|
Wu G, Tan J, Li J, Sun X, Du L and Tao S:
miRNA-145-5p induces apoptosis after ischemia-reperfusion by
targeting dual specificity phosphatase 6. J Cell Physiol: Mar 18,
2019 (Epub ahead of print).
|
|
13
|
Shimokawa H, Sunamura S and Satoh K:
RhoA/Rho-kinase in the cardiovascular system. Circ Res.
118:352–366. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shimokawa H: 2014 Williams harvey lecture:
Importance of coronary vasomotion abnormalities-from bench to
bedside. Eur Heart J. 35:3180–3193. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kandabashi T, Shimokawa H, Miyata K,
Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S,
Kaibuchi K and Takeshita A: Inhibition of myosin phosphatase by
upregulated rho-kinase plays a key role for coronary artery spasm
in a porcine model with interleukin-1beta. Circulation.
101:1319–1323. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ikeda S, Satoh K, Kikuchi N, Miyata S,
Suzuki K, Omura J, Shimizu T, Kobayashi K, Kobayashi K, Fukumoto Y,
et al: Crucial role of rho-kinase in pressure overload-induced
right ventricular hypertrophy and dysfunction in mice. Arterioscler
Thromb Vasc Biol. 34:1260–1271. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Uehata M, Ishizaki T, Satoh H, Ono T,
Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M
and Narumiya S: Calcium sensitization of smooth muscle mediated by
a Rho-associated protein kinase in hypertension. Nature.
389:990–994. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Shimizu T, Fukumoto Y, Tanaka S, Satoh K,
Ikeda S and Shimokawa H: Crucial role of ROCK2 in vascular smooth
muscle cells for hypoxia-induced pulmonary hypertension in mice.
Arterioscler Thromb Vasc Biol. 33:2780–2791. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Xiang SY, Vanhoutte D, Del Re DP, Purcell
NH, Ling H, Banerjee I, Bossuyt J, Lang RA, Zheng Y, Matkovich SJ,
et al: RhoA protects the mouse heart against ischemia/reperfusion
injury. J Clin Invest. 121:3269–3276. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Riento K and Ridley AJ: Rocks:
Multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol.
4:446–456. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Chang J, Xie M, Shah VR, Schneider MD,
Entman ML, Wei L and Schwartz RJ: Activation of Rho-associated
coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays
an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci
USA. 103:14495–14500. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yue X, Yang X, Lin X, Yang T, Yi X, Dai Y,
Guo J, Li T, Shi J, Wei L, et al: Rnd3 haploinsufficient mice are
predisposed to hemodynamic stress and develop apoptotic
cardiomyopathy with heart failure. Cell Death Dis.
5(e1284)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hartmann S, Ridley AJ and Lutz S: The
function of Rho-associated kinases ROCK1 and ROCK2 in the
pathogenesis of cardiovascular disease. Front Pharmacol.
6(276)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shi J, Zhang YW, Yang Y, Zhang L and Wei
L: ROCK1 plays an essential role in the transition from cardiac
hypertrophy to failure in mice. J Mol Cell Cardiol. 49:819–828.
2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Degterev A, Boyce M and Yuan J: A decade
of caspases. Oncogene. 22:8543–8567. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Boon RA, Jaé N, Holdt L and Dimmeler S:
Long noncoding RNAs: From clinical genetics to therapeutic targets?
J Am Coll Cardiol. 67:1214–1226. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vacante F, Denby L, Sluimer JC and Baker
AH: The function of miR-143, miR-145 and the MiR-143 host gene in
cardiovascular development and disease. Vascul Pharmacol.
112:24–30. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hu S, Cao S, Tong Z and Liu J: FGF21
protects myocardial ischemia-reperfusion injury through reduction
of miR-145-mediated autophagy. Am J Transl Res. 10:3677–3688.
2018.PubMed/NCBI
|
|
30
|
Zhang J, Li XX, Bian HJ, Liu XB, Ji XP and
Zhang Y: Inhibition of the activity of Rho-kinase reduces
cardiomyocyte apoptosis in heart ischemia/reperfusion via
suppressing JNK-mediated AIF translocation. Clin Chim Acta.
401:76–80. 2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang J, Xu F, Liu XB, Bi SJ and Lu QH:
Increased Rho kinase activity in patients with heart
ischemia/reperfusion. Perfusion. 34:15–21. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Strassheim D, Gerasimovskaya E, Irwin D,
Dempsey EC, Stenmark K and Karoor V: RhoGTPase in vascular disease.
Cells. 8(551)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shimizu T and Liao JK: Rho kinases and
cardiac remodeling. Circ J. 80:1491–1498. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sunamura S, Satoh K, Kurosawa R, Ohtsuki
T, Kikuchi N, Elias-Al-Mamun M, Shimizu T, Ikeda S, Suzuki K, Satoh
T, et al: Different roles of myocardial ROCK1 and ROCK2 in cardiac
dysfunction and postcapillary pulmonary hypertension in mice. Proc
Natl Acad Sci USA. 115:E7129–E7138. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhuang S, Liu F and Wu P: Upregulation of
long noncoding RNA TUG1 contributes to the development of
laryngocarcinoma by targeting miR-145-5p/ROCK1 axis. J Cell
Biochem. 120:13392–13402. 2019.PubMed/NCBI View Article : Google Scholar
|
